prednisone has been researched along with Cognition Disorders in 38 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We assessed the long-term cognitive and seizure outcomes of 37 patients with cryptogenic infantile spasms (onset, age 3 to 9 months) receiving standardized treatment regimen of high-dose tetracosactide depot, 1 mg IM every 48 h for 2 weeks, with a subsequent 8- to 10-week slow taper and followed by oral prednisone, 10 mg/day for a month, with a subsequent slow taper for 5 months or until the infant reached the age of 1 year, whichever came later." | 3.72 | Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. ( Ariel, R; Danziger, Y; Kivity, S; Lerman, P; Mimouni, M; Shinnar, S, 2004) |
| "Baseline responses on the Alzheimer's Disease Assessment Scale - Cognitive, Clinical Dementia Rating, and the Mini-Mental State Examination were obtained from two clinical trials (n = 138 and n = 351)." | 2.74 | Agreement in cognitive and clinical assessments in Alzheimer's disease. ( Aisen, PS; Tractenberg, RE, 2009) |
| "Many patients with systemic lupus erythematosus have central nervous system involvement." | 1.39 | Resolution of neuropsychological and FDG-PET abnormalities in a patient with neuropsychiatric systemic lupus erythematosus. ( Adeli, A; Drubach, DA; Machulda, MM, 2013) |
| "Physical examination showed hemiparesis and cerebellar ataxia." | 1.38 | Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs. ( Beyne-Rauzy, O; Brechemier, D; Dugert, E; Hitzel, A; Julian, A; Le Guellec, S; Wagner, T, 2012) |
| "We report a case of Susac's syndrome in which the patient improved immediately after tumour necrosis factor (TNF) inhibition with the monoclonal antibody, infliximab." | 1.37 | Tumour necrosis factor (TNF) inhibitor therapy in Susac's syndrome. ( Barnett, MH; Fulham, MJ; Garsia, RJ; Halmagyi, GM; Hardy, TA; Harrisberg, B; Lewis, SJ, 2011) |
| "Kinsbourne syndrome or opsoclonus myoclonus syndrome (OMS) is characterized by rapid, involuntary, irregular conjugate eye movements (opsoclonus), myoclonic jerking of the limbs and trunk, ataxia, and behavioral disturbances." | 1.35 | Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up. ( Aarsen, FK; Catsman-Berrevoets, CE; Hakvoort-Cammel, FG; van den Heuvel-Eibrink, MM; van Hemsbergen, ML; van Noesel, MM, 2009) |
| "Morvan's syndrome is characterized by peripheral nervous system hyperexcitibility (myokymia and neuromyotonia), hyperhydrosis, sleep disorder, limb paresthesias, and encephalopathy." | 1.35 | Reduplicative paramnesia in Morvan's syndrome. ( Anderson, CA; Filley, CM; Hudson, LA; Johnston-Brooks, C; Rollins, YD; Tyler, KL, 2008) |
| "Sarcoidosis is a multisystemic disease which diagnosis depends on the presence of nonnecrotizing granulomas in the biopsy." | 1.35 | [Necrotizing systemic sarcoidosis with pulmonary and central nervous system involvement]. ( Callejas-Rubio, JL; Guerrero Fernández, M; Ortego-Centeno, N; Ríos Fernández, R; Serrano Falcón, MM, 2008) |
| "Susac syndrome is a rare disorder with a clinical triad of encephalopathy, branch retinal artery occlusions, and hearing loss." | 1.34 | [Susac syndrome and ocular manifestation in a 14-year-old girl]. ( Laroche, L; Momtchilova, M; Pelosse, B; Saliba, M, 2007) |
| "The inflammatory hypothesis of Alzheimer's disease (AD), which is supported both by basic laboratory evidence and epidemiological studies, suggests that treatment with anti-inflammatory drugs may reduce the risk or slow the progression of AD." | 1.31 | Anti-inflammatory therapy for Alzheimer's disease: implications of the prednisone trial. ( Aisen, PS, 2000) |
| "Susac's syndrome is a rare disorder characterized by the triad of microangiopathy of the brain and retina with hearing loss." | 1.31 | Susac's syndrome: beneficial effects of corticosteroid therapy in a Japanese case. ( Hashimoto, Y; Tashima, K; Uchino, M; Uyama, E; Yonehara, T, 2001) |
| "Infants diagnosed with acute lymphoblastic leukemia (ALL) are considered the patient subgroup at the highest risk for central nervous system (CNS) disease, both at presentation and as an isolated extramedullary relapse." | 1.30 | Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report. ( Kaleita, TA; MacLean, WE; Reaman, GH; Sather, HN; Whitt, JK, 1999) |
| "Prednisone was reported to be helpful in 79% of patients who received it during the acute phase of the syndrome." | 1.29 | The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset. ( Clauw, DJ; Espinoza, LR; Hertzman, PA; Kaufman, LD; Mease, P; Pincus, T; Silver, RM; Thacker, HL; Varga, J, 1995) |
| "The dementia was characterized by deficits in memory retention, attention, concentration, mental speed and efficiency, and occupational performance." | 1.27 | Reversible steroid dementia in patients without steroid psychosis. ( Alexander, B; MacIndoe, JH; Varney, NR, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (13.16) | 18.7374 |
| 1990's | 6 (15.79) | 18.2507 |
| 2000's | 16 (42.11) | 29.6817 |
| 2010's | 11 (28.95) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fangtham, M | 1 |
| Petri, M | 2 |
| Adeli, A | 1 |
| Drubach, DA | 1 |
| Machulda, MM | 1 |
| Manríquez, J | 1 |
| Berroeta-Mauriziano, D | 1 |
| Andino-Navarrete, R | 1 |
| Vera-Kellet, C | 1 |
| Zimmer, P | 1 |
| Mierau, A | 1 |
| Bloch, W | 1 |
| Strüder, HK | 1 |
| Hülsdünker, T | 1 |
| Schenk, A | 1 |
| Fiebig, L | 1 |
| Baumann, FT | 1 |
| Hahn, M | 1 |
| Reinart, N | 1 |
| Hallek, M | 1 |
| Elter, T | 1 |
| Gauthier, AC | 1 |
| Baehring, JM | 1 |
| Tractenberg, RE | 1 |
| Aisen, PS | 2 |
| Catsman-Berrevoets, CE | 1 |
| Aarsen, FK | 1 |
| van Hemsbergen, ML | 1 |
| van Noesel, MM | 1 |
| Hakvoort-Cammel, FG | 1 |
| van den Heuvel-Eibrink, MM | 1 |
| Mariani, M | 1 |
| Shammi, P | 1 |
| Ruocco, AC | 1 |
| Lacy, M | 1 |
| Gataullina, S | 1 |
| Dulac, O | 1 |
| Catananti, C | 1 |
| Mastropaolo, S | 1 |
| Calabrese, C | 1 |
| Silveri, MC | 1 |
| Onder, G | 1 |
| Hardy, TA | 1 |
| Garsia, RJ | 1 |
| Halmagyi, GM | 1 |
| Lewis, SJ | 1 |
| Harrisberg, B | 1 |
| Fulham, MJ | 1 |
| Barnett, MH | 1 |
| Wagner, T | 1 |
| Brechemier, D | 1 |
| Dugert, E | 1 |
| Le Guellec, S | 1 |
| Julian, A | 1 |
| Hitzel, A | 1 |
| Beyne-Rauzy, O | 1 |
| Kivity, S | 1 |
| Lerman, P | 1 |
| Ariel, R | 1 |
| Danziger, Y | 1 |
| Mimouni, M | 1 |
| Shinnar, S | 1 |
| Berroya, AG | 1 |
| McIntyre, J | 1 |
| Webster, R | 1 |
| Lah, S | 1 |
| Sabaz, M | 1 |
| Lawson, J | 1 |
| Bleasel, AF | 1 |
| Bye, AM | 1 |
| Hussain, NS | 1 |
| Rumbaugh, J | 1 |
| Kerr, D | 1 |
| Nath, A | 1 |
| Hillis, AE | 1 |
| McLaurin, EY | 1 |
| Holliday, SL | 1 |
| Williams, P | 1 |
| Brey, RL | 1 |
| Halperin, JJ | 1 |
| Shapiro, ED | 1 |
| Logigian, E | 1 |
| Belman, AL | 1 |
| Dotevall, L | 1 |
| Wormser, GP | 1 |
| Krupp, L | 1 |
| Gronseth, G | 1 |
| Bever, CT | 1 |
| Hudson, LA | 1 |
| Rollins, YD | 1 |
| Anderson, CA | 1 |
| Johnston-Brooks, C | 1 |
| Tyler, KL | 1 |
| Filley, CM | 1 |
| Saliba, M | 1 |
| Pelosse, B | 1 |
| Momtchilova, M | 1 |
| Laroche, L | 1 |
| Ríos Fernández, R | 1 |
| Callejas-Rubio, JL | 1 |
| Guerrero Fernández, M | 1 |
| Serrano Falcón, MM | 1 |
| Ortego-Centeno, N | 1 |
| Varney, NR | 1 |
| Alexander, B | 1 |
| MacIndoe, JH | 1 |
| Hertzman, PA | 1 |
| Clauw, DJ | 1 |
| Kaufman, LD | 1 |
| Varga, J | 1 |
| Silver, RM | 1 |
| Thacker, HL | 1 |
| Mease, P | 1 |
| Espinoza, LR | 1 |
| Pincus, T | 1 |
| Ghika-Schmid, F | 1 |
| Ghika, J | 1 |
| Regli, F | 1 |
| Dworak, N | 1 |
| Bogousslavsky, J | 1 |
| Städler, C | 1 |
| Portmann, L | 1 |
| Despland, PA | 1 |
| Glanz, BI | 1 |
| Slonim, D | 1 |
| Urowitz, MB | 1 |
| Gladman, DD | 1 |
| Gough, J | 1 |
| MacKinnon, A | 1 |
| Kaleita, TA | 1 |
| Reaman, GH | 1 |
| MacLean, WE | 1 |
| Sather, HN | 1 |
| Whitt, JK | 1 |
| Leritz, E | 1 |
| Brandt, J | 1 |
| Minor, M | 1 |
| Reis-Jensen, F | 1 |
| Tashima, K | 1 |
| Uyama, E | 1 |
| Hashimoto, Y | 1 |
| Yonehara, T | 1 |
| Uchino, M | 1 |
| O'Neill, BP | 1 |
| Wang, CH | 1 |
| O'Fallon, JR | 1 |
| Colgan, JP | 1 |
| Earle, JD | 1 |
| Krigel, RL | 1 |
| Brown, LD | 1 |
| McGinnis, WJ | 1 |
| Kingma, A | 1 |
| Van Dommelen, RI | 1 |
| Mooyaart, EL | 1 |
| Wilmink, JT | 1 |
| Deelman, BG | 1 |
| Kamps, WA | 1 |
| Kadan-Lottick, N | 1 |
| Neglia, JP | 1 |
| Calvet, D | 1 |
| Touzé, E | 1 |
| Delegue, P | 1 |
| Bertherat, J | 1 |
| Zuber, M | 1 |
| Wolkowitz, OM | 1 |
| Reus, VI | 1 |
| Weingartner, H | 1 |
| Thompson, K | 1 |
| Breier, A | 1 |
| Doran, A | 1 |
| Rubinow, D | 1 |
| Pickar, D | 1 |
| Basavaraju, N | 1 |
| Phillips, SL | 1 |
| Joffe, RT | 1 |
| Denicoff, KD | 1 |
| Rubinow, DR | 1 |
| Tsokos, G | 1 |
| Balow, JE | 1 |
| Pillemer, SE | 1 |
| Brouwers, P | 1 |
| Riccardi, R | 1 |
| Fedio, P | 1 |
| Poplack, DG | 1 |
| Mannheimer, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone[NCT03187743] | 72 participants (Actual) | Interventional | 2018-04-17 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for prednisone and Cognition Disorders
| Article | Year |
|---|---|
2013 update: Hopkins lupus cohort.
Topics: Antirheumatic Agents; Cardiovascular Diseases; Cognition Disorders; Cohort Studies; Creatinine; Gluc | 2013 |
Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition?
Topics: Adult; Aged; Anti-Inflammatory Agents; Anticonvulsants; Brain; Clonazepam; Cognition Disorders; Elec | 1996 |
2 trials available for prednisone and Cognition Disorders
| Article | Year |
|---|---|
Agreement in cognitive and clinical assessments in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents; Cognition; Cognition Disorders; Cohort Studies; D | 2009 |
The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: cognitive function and performance status. North Central Cancer Treatment Group.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neo | 1999 |
34 other studies available for prednisone and Cognition Disorders
| Article | Year |
|---|---|
Resolution of neuropsychological and FDG-PET abnormalities in a patient with neuropsychiatric systemic lupus erythematosus.
Topics: Brain; Cerebral Cortex; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three- | 2013 |
[Scleromyxedema with neurological symptoms: successful treatment with immunoglobulins].
Topics: Cognition Disorders; Female; Humans; Immunoglobulins, Intravenous; Middle Aged; Prednisone; Scleromy | 2015 |
Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab a
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bendamustine Hydrochloride; Bra | 2015 |
Hashimoto's encephalopathy mimicking Creutzfeldt-Jakob disease.
Topics: Anti-Inflammatory Agents; Ataxia; Cognition Disorders; Confusion; Creutzfeldt-Jakob Syndrome; Diagno | 2017 |
Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up.
Topics: Adolescent; Adrenocorticotropic Hormone; Child; Child, Preschool; Cognition Disorders; Female; Follo | 2009 |
Neurosarcoidosis and associated neuropsychological sequelae: a rare case of isolated intracranial involvement.
Topics: Anti-Inflammatory Agents; Azathioprine; Basal Ganglia; Cognition Disorders; Female; Frontal Lobe; Hu | 2010 |
Neuropsychological findings in a case of neurosarcoidosis.
Topics: Adult; Anti-Inflammatory Agents; Brain; Cognition Disorders; Female; Humans; Neuropsychological Test | 2010 |
Rassmussen's encephalitis: are there new, better therapeutic medical and surgical guidelines?
Topics: Anti-Inflammatory Agents; Atrophy; Brain; Child; Child, Preschool; Cognition Disorders; Electroencep | 2010 |
A case of normal-pressure hydrocephalus associated with rheumatoid arthritis.
Topics: Activities of Daily Living; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumat | 2010 |
Tumour necrosis factor (TNF) inhibitor therapy in Susac's syndrome.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Brain; Cognition Disorders; Cyclopho | 2011 |
Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone M | 2012 |
Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone.
Topics: Administration, Oral; Brain; Child; Child, Preschool; Cognition Disorders; Cohort Studies; Cosyntrop | 2004 |
Speech and language deterioration in benign rolandic epilepsy.
Topics: Anomia; Anticonvulsants; Carbamazepine; Cerebral Cortex; Child; Child, Preschool; Cognition Disorder | 2004 |
Effects of prednisone and plasma exchange on cognitive impairment in Hashimoto encephalopathy.
Topics: Administration, Oral; Cognition Disorders; Combined Modality Therapy; Female; Humans; Middle Aged; P | 2005 |
Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Aspirin; Autoant | 2005 |
Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Borrelia burgdorferi; Child; Chronic Disease; Co | 2007 |
Reduplicative paramnesia in Morvan's syndrome.
Topics: Anti-Inflammatory Agents; Autoantibodies; Cognition Disorders; Electromyography; Humans; Immunoglobu | 2008 |
[Susac syndrome and ocular manifestation in a 14-year-old girl].
Topics: Adolescent; Brain; Brain Ischemia; Cognition Disorders; Diagnosis, Differential; Disease Progression | 2007 |
[Necrotizing systemic sarcoidosis with pulmonary and central nervous system involvement].
Topics: Adult; Antitubercular Agents; Brain Diseases; Cognition Disorders; Diagnostic Errors; Epilepsy, Toni | 2008 |
Reversible steroid dementia in patients without steroid psychosis.
Topics: Adult; Aged; Alzheimer Disease; Attention; Cognition Disorders; Cortisone; Dementia; Diagnosis, Diff | 1984 |
The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset.
Topics: Adult; Aged; Aged, 80 and over; Cognition Disorders; Eosinophilia-Myalgia Syndrome; Female; Follow-U | 1995 |
Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus.
Topics: Adult; Aged; Anti-Inflammatory Agents; Atrophy; Brain; Cognition Disorders; Female; Humans; Lupus Er | 1997 |
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Damage, Chronic; Cognition Disor | 1999 |
"Subcortical" cognitive impairment in patients with systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Brain; Cognition Disorders; Fe | 2000 |
Anti-inflammatory therapy for Alzheimer's disease: implications of the prednisone trial.
Topics: Alzheimer Disease; Anti-Inflammatory Agents; Cognition Disorders; Cyclooxygenase 2; Humans; Inflamma | 2000 |
Susac's syndrome: beneficial effects of corticosteroid therapy in a Japanese case.
Topics: Adult; Anti-Inflammatory Agents; Asian People; Asthma; Ataxia; Brain; Cognition Disorders; Confusion | 2001 |
No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Attention; Child, Preschool; Cognition | 2002 |
Pediatric acute lymphoblastic leukemia: redefining outcomes.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Attention; Child; Child, Preschool; Cogn | 2002 |
[Stiff limb syndrome associated with Hashimoto's encephalopathy: improvement after corticotherapy].
Topics: Aged; Antibody Specificity; Anticonvulsants; Antithyroid Agents; Autoantibodies; Autoimmune Diseases | 2002 |
Cognitive effects of corticosteroids.
Topics: Adrenal Cortex Hormones; Arousal; Cognition; Cognition Disorders; Depressive Disorder; Dexamethasone | 1990 |
Cortisol deficient state. A cause of reversible cognitive impairment and delirium in the elderly.
Topics: Activities of Daily Living; Aged; Cognition Disorders; Delirium; Female; Humans; Hydrocortisone; Hyp | 1989 |
Mood effects of alternate-day corticosteroid therapy in patients with systemic lupus erythematosus.
Topics: Adult; Anxiety Disorders; Cognition Disorders; Depressive Disorder; Drug Administration Schedule; Fe | 1988 |
Long-term neuropsychologic sequelae of childhood leukemia: correlation with CT brain scan abnormalities.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cognition Disor | 1985 |
[Confusion of uncertain etiology in Hodgkin's disease].
Topics: Aged; Cognition Disorders; Female; Herpes Zoster; Hodgkin Disease; Humans; Mechlorethamine; Predniso | 1974 |